Space, the final frontier. These are the voyages of the starship Your Wrist, whose bold 80+ year mission is to help you carry grocery bags and wear watches like the Luminox XCOR 5261 Chronograph. This unique automatic chronograph from a watchmaker most known for brightly luminous and rugged timepieces, is an homage to spaceflight and looks pretty darn cool. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) announced that the European Commission has granted Orphan Designation in the European Union for the Company’s novel synthetic oral endocannabinoid-mimetic drug, Resunab, for the treatment of cystic fibrosis (“CF”). Read more >>
XCOR’s aim is for daily space flights. Watch this interview with XCOR founder Jeff Greason. Watch now >>
Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has completed the Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis (“systemic sclerosis”). Corbus expects to report topline data from this study in the fourth quarter of 2016. Read more >>
With a high-speed camera that live-streams video, goggles give visually impaired users a new look at lifeZiad
Alex Curtis’ grandchildren think the thick goggles make him look like a spaceman. With the dark lenses and the cord snaking down to a set of dials and controls, the device does look futuristic.
But what people see when Curtis wears the eSight device doesn’t matter to him. Read more >>
A mother in Wisconsin hopes to one day be able to read to her children. Right now, it’s difficult for her to do that since she is legally blind.
Stephanie Geiger from Grand Chute was diagnosed with Cone Rod Dystrophy at the age of 24. It’s difficult for her to see depth perception, certain colors, and details.
Recently, she got to try out eSight eyewear which uses high optics and resolution procession to improve eye sight. […]
Sean Ainsworth, the CEO of Ann Arbor-based RetroSense Therapeutics LLC, will be honored as entrepreneur of the year Thursday night at TechTown Detroit’s annual Toast of the Town awards program. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (CRBP) a clinical stage drug development company targeting rare, chronic and serious inflammatory and fibrotic diseases, announced that Professor Derek Gilroy, Ph.D. presented data on the effects of Resunab in a model of inflammation in healthy volunteers on September 28, 2016. The presentation was made at the 6th European Workshop on Lipid Mediators at Goethe University in Frankfurt am Main, Germany. Read more >>